Skip to main content

Table 2 Lesion and procedural characteristics

From: Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention

Tertiles of CV of HbA1c

T1 (0.005–0.045)

T2 (0.045–0.086)

T3 (0.086–0.397)

P

Left mainstem lesion

4 (1.82)

4 (1.73)

8 (3.38)

0.363

Left anterior descending lesion

104 (47.27)

96 (41.56)

92 (38.82)

Circumflex lesion

65 (29.55)

65 (28.14)

71 (29.96)

Right coronary lesion

47 (21.36)

66 (28.57)

66 (27.85)

Multivessel disease

109 (77.3)

103 (74.1)

114 (81.4)

0.338

RD, pre-PCI, mm

2.96 ± 0.51

2.91 ± 0.43

2.88 ± 0.44

0.176

%DS pre-PCI

81.82 ± 18.21

78.66 ± 24.75

81.52 ± 24.79

0.278

MLD pre-PCI, mm

0.54 ± 0.55

0.62 ± 0.72

0.55 ± 0.77

0.385

RD, post-PCI, mm

3.17 ± 0.81

3.14 ± 0.94

3.13 ± 0.91

0.858

%DS post-PCI

12.89 ± 13.27

14.69 ± 13.44

13.42 ± 15.06

0.370

MLD post-PCI, mm

2.78 ± 0.87

2.70 ± 0.98

2.73 ± 0.98

0.696

Stent count

1.45 ± 0.64

1.53 ± 0.71

1.48 ± 0.72

0.409

Stented length, mm

36.76 ± 17.88

38.24 ± 20.72

37.11 ± 18.98

0.692

  1. CV coefficient of variation, DS diameter stenosis, MLD minimal luminal diameter, RD reference diameter, PCI percutaneous coronary intervention